Pharmaceutical manufacturers of Sevoflurane

Hengrui Medicine is a prominent pharmaceutical corporation situated in China, focusing on the exploration, production, manufacturing, and marketing of groundbreaking and superior healthcare goods. It underwent restructuring into a joint-stock company in 1997 and was subsequently listed on the Shanghai Stock Exchange under stock code 600276 in 2000. With a market capitalization exceeding 55 billion USD, the company is ranked among the top 30 pharmaceutical firms globally and employs over 21,900 personnel worldwide. Hengrui is recognized as a pioneer in the field of cancer medications, contrast agents, and surgical innovations.

We represent Lunan Pharmaceutical Group, a joint venture based in China, specialized in the production and exportation of APIs and finished medications. The consortium consists of seven affiliated firms, including Lunan Hope Pharmaceutical Co., LTD., Lunan Better Pharmaceutical Co., LTD., Shandong New Time Pharmaceutical Co., LTD., and Lunan New Time Bio-Tech Co., LTD., among others

Apollo Scientific presents an extensive variety of organic intermediates (currently exceeding 75,000). In our dedicated laboratories in the UK, we produce fluorochemicals and essential heterocyclic building blocks in quantities ranging from small amounts to over 50kg

Lunan Pharma is a prominent pharmaceutical firm dedicated to enhancing human well-being through the production and promotion of top-quality pharmaceutical products. The company achieved total sales revenues of 1.8 billion dollars in 2020 and is ranked among the top 22 in China.

Founded in 1997 and headquartered in Zhuhai, China, our company is dedicated to the development, manufacturing, and promotion of cost-effective, high-quality generic drugs and API. Our product line focuses on the fundamental therapeutic areas of Cardiovascular, Gastrointestinal, and CNS. We have been acknowledged for our compliance with cGMP and ICH guidelines by regulatory authorities such as NMPA, USFDA, PMDA, and MFDS (Korea). Zhuhai Rundu Pharmaceutical Co., Ltd. is a contemporary scientific and technological pharmaceutical enterprise that integrates drug research and development, production, and distribution. Situated in Jinwan District, Zhuhai City, Guangdong Province, it was established in 1999 and became publicly listed on the Shenzhen Stock Exchange on January 5, 2018 (stock abbreviation: Rundu; stock code: 002923). The company's primary operations revolve around the research and development, production, and sales of chemical-pharmaceutical preparations, chemical raw materials, and pharmaceutical intermediates.

Central Glass Germany is committed to the advancement of processing, scale-up, and manufacturing of active substances and intermediates for the pharmaceutical and beauty industry. It operates a facility in Halle-Westphalia that has been inspected by FDA and EU. A proficient and highly skilled team of organic chemists and supporting roles, such as analytical experts and our QA/QC team, ensure achievement and exceptional quality.